InsidersTradesSigma
Bluejay Diagnostics, Inc.: insider trades · United States · SEC (Form 4)
SEC:bluejay-diagnostics-inc-6cd1d2US·SEC (Form 4)Mcap 2M€Healthcare
Discover the full management transaction log of Bluejay Diagnostics, Inc., a listed issuer based in United States. Shares are quoted on US US, under the oversight of SEC (Form 4). Operating in the Healthcare sector, Bluejay Diagnostics, Inc. has published 6 reports. Market capitalisation: €1.8m. The latest transaction was filed on 27 April 2022 — Acquisition. Among the most active insiders: Kinder Gordon Winston. The full history is openly available.
6
Insider Decl.
0
Thresholds
€143,338
6 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
1.73 €
Analyst consensus
Income statement
Net income−6.8 M€0.0% margin
Valuation
P/Book0.4x
Balance sheet & cash
Market cap1.8 M€
Total debt120 k€
Free Cash Flow−6.2 M€
Debt / Equity2%
Profitability & ownership
ROE-171.6%
ROA-80.1%
% insiders5.2%
% institutions5.7%
Last declaration on 27 April 2022
Declarations6 total
Executives▲Purchase44SEC
€18,48020,000 shares@ €0.9241.03% mcap100.0% of flow
Common Stock
SEC:0001213900-22-021923:0·
Ideal exit: 20 Jan 2023 (T+270)
Executives▲Purchase◆Signal · 53SEC
€2,6292,500 shares@ €1.05150.15% mcap22.4% of flow
Common Stock
SEC:0001213900-22-013794:0·
Ideal exit: 12 Dec 2022 (T+270)
Executives▲Purchase◆Signal · 53SEC
€10,73310,000 shares@ €1.07330.60% mcap100.0% of flow
Common Stock
SEC:0001213900-22-013761:0·
Ideal exit: 12 Dec 2022 (T+270)
Executives▲Purchase◆Signal · 54SEC
€42,75140,000 shares@ €1.06882.39% mcap41.8% of flow
Common Stock
SEC:0001213900-22-013510:0·
Ideal exit: 12 Dec 2022 (T+270)
Executives▲Purchase◆Signal · 55SEC
€59,62160,000 shares@ €0.99373.33% mcap58.2% of flow
Common Stock
SEC:0001213900-22-013129:0·
Ideal exit: 11 Dec 2022 (T+270)
Executives▲Purchase◆Signal · 60SEC
€9,12510,500 shares@ €0.8690.51% mcap77.6% of flow
Common Stock
SEC:0001213900-22-013084:0·
Ideal exit: 9 Dec 2022 (T+270)
6 of 6 declarations